Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Journal of hepatology - 1 Jul 2011

Frau Maddalena, Ladu Sara, Calvisi Diego F, Simile Maria M, Bonelli Piero, Daino Lucia, Tomasi Maria L, Seddaiu Maria A, Feo Francesco, Pascale Rosa M

Abstract excerpt

BACKGROUND & AIMS: MYBL2 is implicated in human malignancies and over expressed in hepatocellular carcinoma (HCC). We investigated Mybl2 role in the acquisition of susceptibility to HCC and tumor progression. METHODS: MYBL2 mRNA and protein levels were evaluated by quantitative RT-PCR and immunoblotting, respectively. MYBL2 expression in HCC cell lines was controlled through MYBL2 cDNA or anti-MYBL2 siRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to E2F1 Transcription Factor
Share to Genes, myb

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hep G2 Cells

Share to Liver Neoplasms, Experimental

Share to Rats, Inbred BN

Share to Rats, Inbred F344

Share to RNA, Neoplasm

Share to RNA, Small Interfering

Source

Identifiers

PMID: 21419759
DOI: 10.1016/j.jhep.2010.10.031

Genes

MYBL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.PMID 21419759Read ↗

Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.Semantic proximity Read ↗

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53Semantic proximity Read ↗

MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma.Semantic proximity Read ↗

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesisSemantic proximity Read ↗

CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasisSemantic proximity Read ↗

The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformaticsSemantic proximity Read ↗

LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinomaSemantic proximity Read ↗

Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosisSemantic proximity Read ↗

TMB Signature-Related RCAN2 Promotes Apoptosis by Upregulating EHF/DR5 Pathway in Hepatocellular Carcinoma.Semantic proximity Read ↗

Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by oncoprotein lossSemantic proximity Read ↗

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.